Asia · Regional markets · CNBC-TV18

Granules India’s Gagillapur facility gets 11 observations in USFDA inspection

Published by CNBC-TV18 · India 2 h ago

The inspection of the finished dosage facility in Hyderabad was conducted from October 19 to October 30. The company said there is no impact on manufacturing or distribution of…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Mint

Nuclear potential, data centre boom may be addressed in new Asean energy masterplan

Korea Economic Daily

Naver founder dilutes stake in $1 bn Nvidia deal to drive global AI push

China Daily Business

Granules India’s Gagillapur facility gets 11 observations in USFDA inspection

Share

Also worth reading

Nasdaq 100 Hits Third Correction of 2026 on Unwinding Tech Stock Bets

Global tech giants' spending spooks investors and drives bonds rally

Containing the Binance hack hinges on vow to make traders whole

Nuclear potential, data centre boom may be addressed in new Asean energy masterplan

Naver founder dilutes stake in $1 bn Nvidia deal to drive global AI push

Eurozone GDP growth slows to 0.4% in Q3: Eurostat